RADT-26. PATTERNS OF RECURRENCE IN PATIENTS TREATED WITH RE-IRRADIATION FOR RECURRENT HIGH-GRADE GLIOMA
نویسندگان
چکیده
Abstract Purpose/Objective(s) Re-irradiation (ReRT) is often used to treat recurrent high grade glioma (HGG). There limited literature regarding the patterns of recurrence following ReRT, which was investigated in current study. Materials/METHODS Patients with available radiation (RT) contours, dosimetry, and imaging-based evidence were included retrospective All patients treated fractionated RT using conformal technique. Recurrence documented as per decision tumor board based on imaging magnetic resonance (MRI) or Flouroethyl-L-Tyrosine (FET) positron emission tomography (PET), registered planning CT. Failure classified in-field, marginal, out-field decided by >50% volume within 95%, 20-95%, outside 20% isodose lines, respectively. RESULTS Study population 37 median dose 54 Gy (range 50.4-54 Gy). Before 92% had undergone surgery (biopsy 3, gross total resection 9, subtotal 22), 62% received concurrent chemo 49% maintenance chemotherapy. Median time 9 months (7-16 months, 10 8 respectively for in-field marginal/out-field recurrence). In-field, seen 24 (65%), (27%), 3 (8%), mapping done MRI, PET, both 27, 7, Of recurrence, 16 disease clinical target volume, 2 leptomeningeal dissemination (1 majority 1 marginal failure addition metastatic disease). CONCLUSION Following ReRT HGG, region, suggesting use conservative volumes. Future studies are required feasibility dose-escalation improve control rates, particularly long intervals from first course RT.
منابع مشابه
Re-Irradiation in Recurrent High-Grade Glioma
Background and Purpose: Despite the progress in treatment modalities such as neurosurgery and radiotherapy, almost all patients treated with malignant gliomas develop recurrent tumors and die of their disease. The aim of this study was to determine response, survival and treatment toxicities after reirradiation of relapsing primary malignant brain gliomas. Material and Methods: Twenty patients ...
متن کاملRe-irradiation alternatives for recurrent high-grade glioma
Despite advances in the fields of surgery, chemotherapy and radiotherapy, the prognosis for high-grade glioma (HGG) remains unsatisfactory. The majority of HGG patients experience disease recurrence. To date, no standard treatments have been established for recurrent HGG. Repeat surgery and chemotherapy demonstrate moderate efficacy. As recurrent lesions are usually located within the previousl...
متن کاملRecurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients
BACKGROUND The aim of the present analysis was to evaluate the recurrence pattern in patients with recurrent malignant glioma after re-irradiation in combination with bevacizumab as there is limited data on how to optimally choose dose, fractionation and delineation margins. METHODS Thirty-one patients with recurrent malignant glioma treated with re-irradiation and bevacizumab after previous ...
متن کاملA Review of the Role of Re-Irradiation in Recurrent High-Grade Glioma (HGG)
Despite the use of more effective multimodal treatments in high-grade glioma (HGG), the outcome of patients affected by this disease is still dismal and recurrence is a very common event. Many therapeutic approaches, alone or combined (surgery, drugs, targeted agents, immunotherapy, radiotherapy, supportive therapy), are available in the clinical armamentarium so far. The attitude of physicians...
متن کاملRecurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy
There is currently no consensus regarding the optimal radiation volume for high-grade glioma (HGG). The brain volume irradiated is associated with the extent of radiation neurotoxicity. When reducing the treatment volume, the risk of geographic tumor miss should be considered. In such cases, the recurrence patterns and, particularly, the rate of marginal tumor recurrence, are important indices ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuro-oncology
سال: 2022
ISSN: ['1523-5866', '1522-8517']
DOI: https://doi.org/10.1093/neuonc/noac209.216